These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 18976206)
41. Mycobacterium ulcerans disease: experience with primary oral medical therapy in an Australian cohort. Friedman ND; Athan E; Hughes AJ; Khajehnoori M; McDonald A; Callan P; Rahdon R; O'Brien DP PLoS Negl Trop Dis; 2013; 7(7):e2315. PubMed ID: 23875050 [TBL] [Abstract][Full Text] [Related]
42. Pharmacologic management of Van Der Werf TS; Barogui YT; Converse PJ; Phillips RO; Stienstra Y Expert Rev Clin Pharmacol; 2020 Apr; 13(4):391-401. PubMed ID: 32310683 [TBL] [Abstract][Full Text] [Related]
43. Triple oral beta-lactam containing therapy for Buruli ulcer treatment shortening. Arenaz-Callao MP; González Del Río R; Lucía Quintana A; Thompson CJ; Mendoza-Losana A; Ramón-García S PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007126. PubMed ID: 30689630 [TBL] [Abstract][Full Text] [Related]
44. Exploration of a standard treatment for Buruli ulcer through a comprehensive analysis of all cases diagnosed in Japan. Sugawara M; Ishii N; Nakanaga K; Suzuki K; Umebayashi Y; Makigami K; Aihara M J Dermatol; 2015 Jun; 42(6):588-95. PubMed ID: 25809502 [TBL] [Abstract][Full Text] [Related]
45. Treatment and prevention of Mycobacterium ulcerans infection (Buruli ulcer) in Australia: guideline update. O'Brien DP; Jenkin G; Buntine J; Steffen CM; McDonald A; Horne S; Friedman ND; Athan E; Hughes A; Callan PP; Johnson PD Med J Aust; 2014 Mar; 200(5):267-70. PubMed ID: 24641151 [TBL] [Abstract][Full Text] [Related]
46. Spontaneous clearance of Mycobacterium ulcerans in a case of Buruli ulcer. Gordon CL; Buntine JA; Hayman JA; Lavender CJ; Fyfe JA; Hosking P; Johnson PD PLoS Negl Trop Dis; 2011 Oct; 5(10):e1290. PubMed ID: 22039555 [No Abstract] [Full Text] [Related]
47. Short report: edematous Mycobacterium ulcerans infection (Buruli ulcer) on the face: a case report. Phanzu DM; Ablordey A; Imposo DB; Lefevre L; Mahema RL; Suykerbuyk P; Meyers WM; Portaels F Am J Trop Med Hyg; 2007 Dec; 77(6):1099-102. PubMed ID: 18165530 [TBL] [Abstract][Full Text] [Related]
48. Confirmed Case of Buruli Ulcer, Senegal, 2018. Turner GA; Seck A; Dieng A; Diadie S; Ndiaye B; van Imeerzeel TD; Diallo M; Kempf M; Bercion R; Boye CS Emerg Infect Dis; 2019 Mar; 25(3):600-601. PubMed ID: 30789331 [TBL] [Abstract][Full Text] [Related]
49. Pharmacokinetics of rifampin and clarithromycin in patients treated for Mycobacterium ulcerans infection. Alffenaar JW; Nienhuis WA; de Velde F; Zuur AT; Wessels AM; Almeida D; Grosset J; Adjei O; Uges DR; van der Werf TS Antimicrob Agents Chemother; 2010 Sep; 54(9):3878-83. PubMed ID: 20585115 [TBL] [Abstract][Full Text] [Related]
50. Report of a series of 82 cases of Buruli ulcer from Nigeria treated in Benin, from 2006 to 2016. Ayelo GA; Anagonou E; Wadagni AC; Barogui YT; Dossou AD; Houezo JG; Aguiar J; Johnson RC; Saizonou R; Asiedu K; Sopoh GE PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006358. PubMed ID: 29522516 [TBL] [Abstract][Full Text] [Related]
52. Secondary Buruli ulcer skin lesions emerging several months after completion of chemotherapy: paradoxical reaction or evidence for immune protection? Ruf MT; Chauty A; Adeye A; Ardant MF; Koussemou H; Johnson RC; Pluschke G PLoS Negl Trop Dis; 2011 Aug; 5(8):e1252. PubMed ID: 21829740 [TBL] [Abstract][Full Text] [Related]
53. Buruli Ulcer, a Prototype for Ecosystem-Related Infection, Caused by Mycobacterium ulcerans. Zingue D; Bouam A; Tian RBD; Drancourt M Clin Microbiol Rev; 2018 Jan; 31(1):. PubMed ID: 29237707 [TBL] [Abstract][Full Text] [Related]
54. Implementation of a decentralized community-based treatment program to improve the management of Buruli ulcer in the Ouinhi district of Benin, West Africa. Amoussouhoui AS; Sopoh GE; Wadagni AC; Johnson RC; Aoulou P; Agbo IE; Houezo JG; Boyer M; Nichter M PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006291. PubMed ID: 29529087 [TBL] [Abstract][Full Text] [Related]
55. Oxazolidinones Can Replace Clarithromycin in Combination with Rifampin in a Mouse Model of Buruli Ulcer. Almeida DV; Omansen TF; Li SY; Lee J; Grosset JH; Converse PJ; Nuermberger EL Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30559131 [TBL] [Abstract][Full Text] [Related]
56. Immunosuppression and treatment-associated inflammatory response in patients with Mycobacterium ulcerans infection (Buruli ulcer). Schütte D; Pluschke G Expert Opin Biol Ther; 2009 Feb; 9(2):187-200. PubMed ID: 19236249 [TBL] [Abstract][Full Text] [Related]